People: Transition Therapeutics Inc (TTH.TO)

TTH.TO on Toronto Stock Exchange

7.51CAD
17 Dec 2014
Price Change (% chg)

$0.26 (+3.46%)
Prev Close
$7.51
Open
$7.92
Day's High
$7.92
Day's Low
$7.40
Volume
3,572
Avg. Vol
1,695
52-wk High
$9.25
52-wk Low
$4.80

Search Stocks

Ashton, Michael 

Brief Biography

Mr. Michael Richard Dwyer Ashton is Lead Independent Director of Transition Therapeutics Inc. Mr. Ashton has been an independent consultant to the pharmaceutical industry since March 2006. Prior thereto, he was the Chief Executive Officer of SkyePharma PLC. He has 30 years of experience in the Pharmaceutical industry having worked for Merck, Pfizer, Purepac and Faulding, where Mr. Ashton was Chairman, President and CEO. Mr. Ashton currently sits on boards of directors of the following public companies; Hikma Pharmaceuticals PLC, and Proximagen Neuroscience PLC.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Tony Cruz

424,876

Nicole Rusaw

316,054

Carl Damiani

199,228

Bruce Connop

287,182

Aleksandra Pastrak

407,711

Louis Alexopoulos

--
As Of 29 Jun 2013
Search Stocks